In this article:
Protocol development in integrative medicine is not typically a simple process. Individuals require individualized care, and what works for one patient may not work for another.
As a result, the Fullscript Integrative Medical Advisory team advises using an evidence-informed approach to protocol development. To simplify this process for practitioners, we have assembled a sampling of evidence-based standardized protocols that practitioners can use as a foundation when developing individualized protocols.
To establish these protocols, we first developed a Rating Scale that could be used to discern the rigor of evidence supporting a specific nutrient’s therapeutic effect.
The following protocols were developed using only A through C-quality evidence. These are categorized as follows:
A Systematic review or meta-analysis
B Randomized Double Blind Placebo Controlled (RDBPC) 2+ studies and/or 1 study with 50 + subjects
C Randomized Double Blind Placebo Controlled (RDBPC) 1 study
Please refer to the complete Rating Scale for further information.
The ingredients included in these protocols are based on a review of existing clinical research, with a priority placed on systematic reviews and meta-analyses, classified as A in the Rating Scale.
These protocols are intended to form a foundation for developing individualized treatment plans. Clinician discretion is highly advised, as ingredients can vary in safety and effectiveness, depending on the needs of the individual patient.
Ingredient-Based Protocol: Irritable Bowel Syndrome
0.1-0.3mL (or 200mg), three times per day1,2,3,4,5
- Significant reduction of abdominal pain and global symptoms, relative to placebo6
- Benefits no longer present two weeks after supplement cessation6
Search for Peppermint Oil in the Fullscript catalog.
Soluble Dietary Fiber
20-35g of long-chain, intermediate viscous, soluble and moderately fermentable dietary fiber7
- Safe and effective in improving global IBS symptoms, relative to placebo8
- Form of soluble fiber used is important, since short-chain soluble and highly fermentable dietary fiber can result in rapid gas production that can aggravate symptoms in patients with IBS9
Search for Fiber in the Fullscript catalog.
25-50 billion CFU, one to three times per day10
- Effective in reducing symptoms and severity score in patients with IBS10
- Specific strain recommendations remain to be concluded11,12
- Current recommendations suggest using an equal dosage of lactobacillus and bifidobacterium species12
Search for Probiotics in the Fullscript catalog.
Adding Protocols to your Fullscript Catalog
Create a Template
- Click the “Prescriptions” button
- Click “Manage your prescription templates”
- Click “Create a new template”
- Add a title, products, dosing, message, and attachments
- Click “Save Template”
Templates can be accessed and applied when creating a new prescription for your patients.
Write a Prescription
- Click the “New Prescription” button
- Click the “Templates” button in the right-hand menu column
- Click the “Apply” button beside the template you wish to apply
- Modify as needed
- Click the “Send to Patient” button!
Create a Category
- Click the Catalog button
- Click the “Your Favorites” tab
- Click “Add Category” and add name
- Add products
Categories can be used for quick reference or for patient use when accessing the catalog (depending on catalog settings).
Visit the Fullscript Integrative Clinical Education Hub for a full review of the literature used to develop this protocol.
We’d be happy to help you create a protocol containing these ingredients in your Fullscript catalog! Contact our Customer Success team for assistance.
1 (C) - https://www.ncbi.nlm.nih.gov/pubmed/11148527
2 (C) - https://www.ncbi.nlm.nih.gov/pubmed/389344
3 (C) - https://www.ncbi.nlm.nih.gov/pubmed/3061106
4 (B) - https://www.ncbi.nlm.nih.gov/pubmed/17420159
5 (B) - https://www.ncbi.nlm.nih.gov/pubmed/9430014
6 (B) - https://www.ncbi.nlm.nih.gov/pubmed/23416804
7 (A) - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548066/
8 (A) - https://www.ncbi.nlm.nih.gov/pubmed/25070054
9 (A) - https://www.ncbi.nlm.nih.gov/pubmed/27372289
10 (A) - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356930/
11 (A) - https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010972.pub2/full?highlightAbstract=irritable%7Cprobiot%7Cbowel%7Cwithdrawn%7Cirrit%7Cprobiotics%7Cirritabl
12 (A) - https://www.ncbi.nlm.nih.gov/pubmed/25070051/